UOKiK
EXTENDS
PROCEEDINGS
ON
WHOLESALE
PHARMACEUTICAL MARKET CONCENTRATION
Poland’s Competition Authority enters second phase of proceedings on Neuca’s bid to
acquire Intra.
[Warsaw, 29 July 2016] In May, Poland’s Office of Competition and Consumer Protection
(UOKiK) received an application seeking approval of Neuca’s takeover of Intra. Both
companies are wholesalers of products to pharmacies and hospitals. In analyzing the
concentration, UOKiK conducted a market study which looked at the two companies’
competitors. It showed that Neuca’s position could be strengthened on a local wholesale
market of pharmaceutical products to pharmacies. This caused UOKiK to extend its
proceedings in the case.
The two-stage procedure
In force since January 2015, Poland’s amended Competition and Consumer Protection Act
lays out a two-stage proceedings model for concentration cases. While UOKiK issues a
decision in the majority of cases in the first, one-month stage, it may extend a proceeding
by four months to issue a decision in cases that are particularly complicated, that require
additional market study to be conducted, or that concern cases covering a concentration
that poses a justifiable likelihood of competition being significantly limited.
The resolution to extend a proceeding does not have any bearing on UOKiK’s ultimate
decision in a case.
Additional information for the media
Press Office, UOKiK
Pl. Powstańców Warszawy 1, 00-950 Warsaw
Phone.: +48 22 827 28 92, +48 22 55 60 314, +48 22 55 60 430
E-mail: [email protected]
Twitter: @UOKiKgovPL